Neuland Laboratories (NSE:NEULANDLAB) COGS-to-Revenue : 0.47 (As of Mar. 2024)

View and export this data going back to 2008. Start your Free Trial

What is Neuland Laboratories COGS-to-Revenue?

Neuland Laboratories's Cost of Goods Sold for the three months ended in Mar. 2024 was ₹1,800 Mil. Its Revenue for the three months ended in Mar. 2024 was ₹3,850 Mil.

Neuland Laboratories's COGS to Revenue for the three months ended in Mar. 2024 was 0.47.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Neuland Laboratories's Gross Margin % for the three months ended in Mar. 2024 was 53.24%.

Neuland Laboratories COGS-to-Revenue Historical Data

The historical data trend for Neuland Laboratories's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neuland Laboratories COGS-to-Revenue Chart

Neuland Laboratories Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

COGS-to-Revenue

Get a 7-Day Free Trial

0.64

0.60

0.52

0.47

Neuland Laboratories Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial															0.51	0.51	0.46	0.45	0.47

Neuland Laboratories COGS-to-Revenue Calculation

Neuland Laboratories's COGS to Revenue for the fiscal year that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	7337.967	/	15585.805
	=	0.47

Neuland Laboratories's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	1800.199	/	3850.097
	=	0.47

Neuland Laboratories (NSE:NEULANDLAB) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Neuland Laboratories's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	1800.199 / 3850.097
	=	53.24 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Neuland Laboratories COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Neuland Laboratories's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Neuland Laboratories (NSE:NEULANDLAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Neuland Laboratories Ltd (NSE:NEULANDLAB) » Definitions » COGS-to-Revenue

Traded in Other Exchanges

524558:India

Address

Road No. 82, Jubilee Hills, Plot No. 573A-III, Phoenix IVY Building, 11th Floor (5th Office Level), Hyderabad, TG, IND, 500033

Website

https://www.neulandlabs.com

Neuland Laboratories Ltd is a manufacturer of active pharmaceutical ingredients (APIs) and an end-to-end solution provider for the pharmaceutical industry's chemistry needs in Hyderabad. Geographically, it derives a majority of revenue from North America and also has a presence in India, Europe, and Rest of the world.

Neuland Laboratories (NSE:NEULANDLAB) Headlines

No Headlines